A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-61803534 and to Evaluate the Effect of JNJ-61803534 on the Pharmacokinetics of Midazolam in Healthy Participants
Clinical trial NCT03139500 · TERMINATED
Trial details
- NCT number
- NCT03139500
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2018-04-05
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.